Desmoid tumors are rare, locally aggressive, highly recurrent soft-tissue tumors without approved treatments. We conducted a phase 3, international, double-blind, randomized, placebo-controlled trial ...

At Huntsman Cancer Institute, you receive comprehensive, multidisciplinary care for sarcoma-adjacent diseases, such as desmoid tumors. Our Sarcoma Care Team provides personalized and compassionate ...

Desmoid tumors (also referred to as aggressive fibromatosis) are connective tissue neoplasms that can arise in any anatomical location and infiltrate the mesentery, neurovascular structures, and ...

Tech That Scales: A Practical Framework for Artificial Intelligence–Enabled Cancer Care in Low- and Middle-Income Countries and Underserved US Counties Desmoid tumors (DTs) are rare fibroblastic ...

Desmoid tumors are noncancerous growths that develop in connective tissue, such as muscle. They can grow almost anywhere in the body. Although these tumors are benign, they can grow fast and may be ...

Targeting the Insulin-Like Growth Factor (IGF) System Is Not as Simple as Just Targeting the Type 1 IGF Receptor Desmoid-type (aggressive) fibromatosis (desmoid tumor) is a soft tissue neoplasm that ...

Desmoid tumors are benign growths that develop in the connective tissues inside the body. Though they’re not considered cancerous, they can be invasive and grow into other, nearby parts of the body.

PARIS — Desmoid tumors are rare, locally aggressive, soft-tissue tumors for which there is no approved systemic therapy — but a novel drug may become the first. Nirogacestat, under development by ...

Brooke was only three years old when she first learned about desmoid tumors. “My mother had six or seven,” she recalls. Brooke’s mother also had 28 surgeries related to her desmoid tumors and multiple ...